Sleep Therapy for Dementia
(SLEEPMATE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a sleep therapy method called Cognitive Behavioral Therapy for Insomnia (CBTi) to determine its effectiveness in helping people with memory problems or dementia, along with their caregivers, sleep better. The goal is to assess whether this treatment, delivered via video calls, is practical and useful. Suitable participants include those diagnosed with Alzheimer's or related memory issues who experience sleep problems at least three times a week. Caregivers living with someone with memory issues and who also have trouble sleeping may qualify. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance sleep quality for many.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this videoconference intervention is safe for individuals with memory loss or dementia?
Research shows that Cognitive Behavioral Therapy for Insomnia (CBTi) safely and effectively improves sleep. Studies have found that CBTi reduces insomnia severity and enhances sleep quality without major side effects. As a therapy rather than a medication, it typically poses fewer risks than drugs. Large reviews of many studies confirm that CBTi is well-tolerated, especially by older adults. This makes it a promising option for those with memory issues or dementia seeking better sleep.12345
Why are researchers excited about this trial?
Cognitive Behavioral Therapy for Insomnia (CBTi) is unique because it uses videoconferencing to deliver therapy sessions, making it more accessible and convenient for participants, especially those with mobility challenges. Unlike typical medications for sleep issues in dementia, which can have side effects or interactions, CBTi focuses on changing sleep habits and thought patterns, offering a non-pharmacological approach. Researchers are excited about this treatment because it has the potential to improve sleep quality without the need for medications, which could lead to better overall management of dementia symptoms.
What evidence suggests that Cognitive Behavioral Therapy for Insomnia is effective for improving sleep in individuals with dementia?
Research shows that Cognitive Behavioral Therapy for Insomnia (CBTi), delivered to participants in this trial through videoconferencing sessions, can help older adults sleep better. Studies have found that CBTi makes falling asleep easier and improves overall sleep quality. One study found that a digital version of CBTi was very helpful for older adults, making it both accessible and effective. Another study showed that group sessions of CBTi improved how quickly people fell asleep and their sleep quality. Early findings also suggest that using video calls for CBTi can enhance sleep quality and satisfaction.35678
Who Is on the Research Team?
Glenna Brewster, PhD, RN, FNP
Principal Investigator
Emory University
Are You a Good Fit for This Trial?
This trial is for older adults experiencing memory loss, cognitive impairment, or dementia and their care partners. They should be willing to participate in a 6-week videoconference program aimed at improving sleep.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 6-week CBTi intervention via videoconferencing sessions
Follow-up
Participants are monitored for changes in sleep onset latency, insomnia, sleep efficiency, and other outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive Behavioral Therapy for Insomnia
Cognitive Behavioral Therapy for Insomnia is already approved in United States, European Union, United Kingdom for the following indications:
- Insomnia
- Depression
- Insomnia
- Depression
- Chronic Insomnia
- Insomnia
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
National Institute on Aging (NIA)
Collaborator